The Rising Burden of Sarcoidosis in England: New Evidence of Increasing Incidence and Significant Mortality Gaps

Highlights of the Population-Based Study

Following a comprehensive analysis of the UK Clinical Practice Research Datalink (CPRD), several critical findings regarding the epidemiology of sarcoidosis in England have emerged:
– The age- and sex-standardized incidence of sarcoidosis rose from 6.65 to 7.73 per 100,000 person-years between 2003 and 2023.
– Disease prevalence has seen a substantial increase, growing from 167 to 230 per 100,000 individuals over the two-decade study period.
– Patients with sarcoidosis face a 36% higher risk of all-cause mortality compared to matched controls, with the most significant excess mortality observed in those aged 30 to 70.
– There is a notable demographic shift, with rising incidence rates particularly evident in males and individuals over the age of 60.

Introduction: Addressing the Epidemiological Void in Sarcoidosis